The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor γ ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 2, 2005, Pages 806-813

  Grommes, Christian ^a   Landreth, Gary E ^a   Schlegel, Uwe ^b   Heneka, Michael T ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 CARBOXY 2 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL]ETHYLAMINO]BENZOIC ACID METHYL ESTER; CASPASE 3; KI 67 ANTIGEN; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SPHEROID CELL;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MIGRATION INHIBITION; CELL MOVEMENT; CELL SURVIVAL; GLIOMA; HUMANS; LIGANDS; OXAZOLES; PPAR GAMMA; RATS; THIAZOLIDINEDIONES; TYROSINE;

EID: 18044386191     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.078972     Document Type: Article

References (18)

1. Berge K, Tronstad KJ, Flindt EN, Rasmussen TH, Madsen L, Kristiansen K, and Berge RK (2001) Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways. Carcinogenesis 22:1747-1755.
2. Brown DC and Gatter KC (2002) Ki67 protein: the immaculate deception? Histopathology 40:2-11.
3. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, and Evans RM (2001) PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7:48-52.
4. Cobb JE, Blanchard SG, Boswell EG, Brown KK, Charifson PS, Cooper JP, Collins JL, Dezube M, Henke BR, Hull-Ryde EA, et al. (1998) N-(2-Benzoylphenyl)- L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent. J Med Chem 41:5055-5069.
5. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114-123.
6. Grommes C, Landreth GE, and Heneka MT (2004) Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol 5:419-429.
7. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, and Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225; discussion, 226-219.
8. Lemberger T, Desvergne B, and Wahli W (1996) Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 12:335-363.
9. Liu H, Zang C, Fenner MH, Possinger K, and Elstner E (2003) PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. Breast Cancer Res Treat 79:63-74.
10. Parkins CS, Darling JL, Gill SS, Revesz T, and Thomas DG (1991) Cell proliferation in serial biopsies through human malignant brain tumours: measurement using Ki67 antibody labelling. Br J Neurosurg 5:289-298.
11. Pedersen PH, Marienhagen K, Mork S, and Bjerkvig R (1993) Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. Cancer Res 53:5158-5165.
12. Sakamoto J, Kimura H, Moriyama S, Odaka H, Momose Y, Sugiyama Y, and Sawada H (2000) Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone. Biochem Biophys Res Commun 278:704-711.
13. Sottocornola E, Colombo I, Vergani V, Taraboletti G, and Berra B (1998) Increased tumorigenicity and invasiveness of C6 rat glioma cells transfected with the human alpha-2,8 sialyl transferase cDNA. Invasion Metastasis 18:142-154.
14. Spencer JP, Rice-Evans C, and Williams RJ (2003) Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278:34783-34793.
15. Suh N, Wang Y, Williams CR, Risingsong R, Gilmer T, Willson TM, and Sporn MB (1999) A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis. Cancer Res 59:5671-5673.
16. Torp SH (2002) Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies. Clin Neuropathol 21:252-257.
17. Willson TM, Brown PJ, Sternbach DD, and Henke BR (2000) The PPARs: from orphan receptors to drug discovery. J Med Chem 43:527-550.
18. Zander T, Kraus JA, Grommes C, Schlegel U, Feinstein D, Klockgether T, Landreth G, Koenigsknecht J, and Heneka MT (2002) Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. J Neurochem 81:1052-1060.